Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity

Di Filippo, Luigi; De Lorenzo, Rebecca; Cinel, Elena; Falbo, Elisabetta; Ferrante, Marica; Cilla, Marta; Martinenghi, Sabina; Vitali, Giordano; Bosi, Emanuele; Giustina, Andrea; Rovere-Querini, Patrizia; Conte, Caterina

BACKGROUND: COVID-19 is associated with unintentional weight loss. Little is known on whether and how patients regain the lost weight. We assessed changes in weight and abdominal adiposity over a three-month follow-up after discharge in COVID-19 survivors. METHODS: In this sub-study of a large prospective observational investigation, we collected data from individuals who had been hospitalized for COVID-19 and re-evaluated at one (V1) and three (V2) months after discharge. Patient characteristics upon admission and anthropometrics, waist circumference and hunger levels assessed during follow-up were analyzed across BMI categories. RESULTS: One-hundred-eighty-five COVID-19 survivors (71% male, median age 62.1 [54.3; 72.1] years, 80% with overweight/obesity) were included. Median BMI did not change from admission to V1 in normal weight subjects (−0.5 [−1.2; 0.6] kg/m(2), p = 0.08), but significantly decreased in subjects with overweight (−0.8 [−1.8; 0.3] kg/m(2), p < 0.001) or obesity (−1.38 [−3.4; −0.3] kg/m(2), p < 0.001; p < 0.05 vs. normal weight or obesity). Median BMI did not change from V1 to V2 in normal weight individuals (+0.26 [−0.34; 1.15] kg/m(2), p = 0.12), but significantly increased in subjects with overweight (+0.4 [0.0; 1.0] kg/m(2), p < 0.001) or obesity (+0.89 [0.0; 1.6] kg/m(2), p < 0.001; p = 0.01 vs. normal weight). Waist circumference significantly increased from V1 to V2 in the whole group (p < 0.001), driven by the groups with overweight or obesity. At multivariable regression analyses, male sex, hunger at V1 and initial weight loss predicted weight gain at V2. CONCLUSIONS: Patients with overweight or obesity hospitalized for COVID-19 exhibit rapid, wide weight fluctuations that may worsen body composition (abdominal adiposity). CLINICALTRIALS.GOV REGISTRATION: NCT04318366.